Skip to main content
Shaoxing Xingxin New Materials Co.,Ltd. logo

Shaoxing Xingxin New Materials Co.,Ltd. — Investor Relations & Filings

Ticker · 001358 ISIN · CNE100006CK7 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 306 across all filing types
Latest filing 2026-05-27 Regulatory Filings
Country CN China
Listing Shenzhen Stock Exchange 001358

About Shaoxing Xingxin New Materials Co.,Ltd.

https://www.xingxinchem.com

Shaoxing Xingxin New Materials Co., Ltd. specializes in the research, development, production, and sales of fine chemical products, with a primary focus on piperazine derivatives and other amine-based chemicals. The company's core product portfolio includes anhydrous piperazine, N-methylpiperazine, N-ethylpiperazine, and triethylenediamine (TEDA). These products serve as critical intermediates and catalysts in various sectors, including pharmaceuticals, agrochemicals, polyurethane materials, and epoxy resin curing agents. By leveraging advanced synthesis technologies and a commitment to green manufacturing, the company has established a significant presence in the global specialty chemicals market. Its operations emphasize high-purity standards and process innovation to meet the rigorous requirements of international clients in the life sciences and industrial materials industries.

Recent filings

Filing Released Lang Actions
国盛证券股份有限公司关于绍兴兴欣新材料股份有限公司使用部分超募资金向全资子公司增资实施新项目并将剩余超募资金永久补充流动资金的核查意见
Regulatory Filings Classification · 85% confidence The document is a sponsor’s due diligence opinion (核查意见) regarding the use of IPO oversubscription funds and internal capital injection. It does not present an annual or interim report, nor is it an earnings release or audit report. Instead, it is a regulatory compliance filing by the sponsor under Chinese securities rules. Therefore, it falls under the general “Regulatory Filings” category (RNS).
2026-05-27 Chinese
第三届董事会第十六次会议决议公告
Regulatory Filings Classification · 82% confidence The document is an announcement of the resolutions of the Company’s Board of Directors meeting (board meeting minutes/resolutions), covering items like the employee share plan lockup, use of oversubscribed funds, and calling a shareholder meeting. It does not contain financial statements (so it’s not an Interim Report), nor is it an executive certification (so not RNS by officer certification specifically), nor does it announce a change in board or senior management personnel. It is a general regulatory announcement of board resolutions, which falls under Regulatory Filings (RNS).
2026-05-27 Chinese
关于召开2026年第二次临时股东会的通知
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a formal notice to convene the company’s 2026 second extraordinary shareholders’ meeting, detailing meeting date, agenda items, voting arrangements, registration procedures, and includes the proxy authorization form. It is sent to solicit shareholder proxies and provide information for voting. This fits the definition of Proxy Solicitation & Information Statement (PSI).
2026-05-27 Chinese
关于2025年员工持股计划第一个锁定期届满暨解锁条件未成就的公告
Regulatory Filings Classification · 82% confidence The document is a formal “公告” (public announcement) by a listed company regarding the expiration of the first lock-up period under its 2025 Employee Stock Ownership Plan and the fact that the unlocking conditions were not met. It contains detailed plan implementation, audit results, and subsequent arrangements, but it is not a management change notice, earnings release, M&A filing, proxy statement, dividend notice, or any other narrow category. It is a routine regulatory disclosure under Shenzhen Stock Exchange rules. Therefore, it falls under the general Regulatory Filings category (RNS).
2026-05-27 Chinese
关于使用部分超募资金向全资子公司增资实施新项目并将剩余超募资金永久补充流动资金的公告
Capital/Financing Update Classification · 90% confidence The document is a formal regulatory announcement by a listed company detailing the proposed use of IPO over-subscription funds (“超募资金”), including capital injection into a wholly-owned subsidiary and permanent supplementation of working capital. It is not an annual or interim report, nor a dividend or earnings release, but an update on the company’s financing activities and capital use decisions. This fits the definition of a Capital/Financing Update (CAP).
2026-05-27 Chinese
关于为子公司提供担保的进展公告
Regulatory Filings Classification · 85% confidence The document is an ad hoc disclosure by a listed Chinese company regarding the progress of providing a bank guarantee to its subsidiary. It does not contain full financial statements or constitute a periodic report (10-K, IR) nor is it an earnings release, AGM material, or M&A filing. It is not a certification letter but a substantive announcement of a business guarantee arrangement. Such ad hoc regulatory announcements that do not fit other specific categories fall under Regulatory Filings (RNS).
2026-05-21 Chinese

Browse filings by year

4 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.